Company / Interest Expense per Share
Travere Therapeutics, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.18
FY2023
5-year range
$0.18 / $0.36
FY2019-FY2023
Trend
-0.1%
vs FY2022
Sector context
#21 of 43
Health Care
What the data says
At $0.18, Travere Therapeutics, Inc.'s interest expense per share ranks #23 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.11 in FY2019 to $0.36 in FY2021.
Based on SEC 10-K filings.
0.18 in FY2023 with a 5-year CAGR of +7.9%.
Improved from $0.36 to $0.18 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -8.3%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
#23 of 43 in Health CareTop 51% of 43This company $0.18 Sector average $18.61
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 0.1% year-over-year.
- Ranks #21 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2021.
- Lowest interest expense per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.18 | -0.1% |
| FY2022 | $0.18 | -51.1% |
| FY2021 | $0.36 | +58.0% |
| FY2020 | $0.23 | +113.1% |
| FY2019 | $0.11 | -11.1% |
| FY2018 | $0.12 | -40.8% |
| FY2017 | $0.20 | +0.1% |
| FY2016 | $0.20 | -31.4% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026